Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Clearside Biomedical, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 53 | 0 |
| Shares | 12.1M | 2.20M | 9.13M | −749.9K (−7.6%) |
| Value | $13.6M | $2.48M | $10.2M | −$939.1K (−8.4%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Clearside Biomedical, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 169,629 | $190.0K | 0.06% |
| Hamilton Lane Advisors LLC | 65,359 | $73.0K | 0.03% |
| Ergoteles LLC | 54,849 | $61.4K | 0.00% |
| Bailard, Inc. | 47,800 | $53.5K | 0.00% |
| Water Island Capital LLC | 47,000 | $52.6K | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $45.0K | 0.00% |
| NewEdge Wealth, LLC | 30,000 | $33.6K | 0.00% |
| Jane Street Group, LLC | 14,232 | $15.9K | 0.00% |
| Two Sigma Securities, LLC | 11,072 | $12.4K | 0.00% |
| Steward Partners Investment Advisory, LLC | 11,000 | $12.3K | 0.00% |
| Soltis Investment Advisors LLC | 10,000 | $11.2K | 0.00% |
| Citadel Advisors LLC | 2,581 | $2.89K | 0.00% |
Sold out (12)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Marshall Wace, LLP | 152,671 | $173.0K |
| Price T Rowe Associates Inc | 23,200 | $27.0K |
| Simplex Trading, LLC | 24,458 | $27.0K |
| Balyasny Asset Management LLC | 22,443 | $25.0K |
| Goldman Sachs Group Inc | 19,308 | $22.0K |
| Private Advisor Group, LLC | 14,900 | $17.0K |
| UBS Group AG | 4,599 | $5.00K |
| Group One Trading, L.P. | 2,648 | $3.00K |
| Tower Research Capital LLC (TRC) | 2,440 | $2.00K |
| China Universal Asset Management Co., Ltd. | 563 | $1.00K |
| Investors Asset Management of Georgia Inc | 250 | $0 |
| Federated Hermes, Inc. | 69 | – |
Not filed for Q4 2022 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 2,197,480 | $2.48M |